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Abstract
Background: While lipopolysaccharide (LPS) from Gram-negative bacteria has been shown to augment inflammation 
in ventilated lungs information on the effect of Gram-positive bacteria is lacking. Therefore the effect of LPS and a 
lipopetide from Gram-positive bacteria, PAM3, on ventilated lungs were investigated.
Methods: C57/Bl6 mice were mechanically ventilated. Sterile saline (sham) and different concentrations of LPS (1 μg 
and 5 μg) and PAM3 (50 nM and 200 nM) were applied intratracheally. Lung function parameters and expression of 
MIP-2 and TNFα as well as influx of neutrophils were measured.
Results: Mechanical ventilation increased resistance and decreased compliance over time. PAM3 but not LPS 
significantly increased resistance compared to sham challenge (P < 0.05). Both LPS and PAM3 significantly increased 
MIP-2 and TNFα mRNA expression compared to sham challenge (P < 0.05). The numbers of neutrophils were 
significantly increased after LPS at a concentration of 5 μg compared to sham (P < 0.05). PAM3 significantly increased 
the numbers of neutrophils at both concentrations compared to sham (P < 0.05).
Conclusions: These data suggest that PAM3 similar to LPS enhances ventilator-induced inflammation. Moreover, PAM3 
but not LPS increases pulmonary resistance in ventilated lungs. Further studies are warranted to define the role of 
lipopetides in ventilator-associated lung injury.
Background
Invasive mechanical ventilation is a life saving approach
in severe respiratory failure. However, large tidal, high
inspiratory pressures, and end-exspiratory alveolar col-
lapse with cyclic reopening can damage the lung paren-
chyma leading to ventilator-induced lung injury (VILI)
[1-6]. Several studies have provided insight into the
pathogenesis of VILI and the underlying inflammatory
processes (reviewed in [7]).
One major problem in mechanically ventilated patients
is ventilator-associated pneumonia (VAP). Incidence
rates in the intensive care unit (ICU) vary from 8% to 28%
[8]. Mortality rates can reach 76% depending on high-risk
pathogens [8]. A number of potential causative factors
have been identified (e. g. orotracheal tube, impaired
mucociliary clearance, severely ill patients, multiresistant
bacteria) [9]. In addition, previous studies have demon-
strated that bacterial products such as lipopolysaccharide
(LPS) from Gram-negative bacteria augment ventilator-
induced inflammation [10-12]. Most of that previous
work has focussed on expression of inflammatory media-
tors and inflammatory cells. Changes in lung function
parameters have been less well characterized. Moreover,
LPS has been administered systemically or intratracheally
before the beginning of ventilation [10-12].
In contrast to LPS, data on the effect of Gram-positive
bacteria on inflammation and lung function in ventilated
lungs are lacking despite the importance of Gram-posi-
tive bacteria in VAP [8]. Therefore we sought to compare
the functional and structural effects of intratracheal
application of Gram-negative and Gram-positive bacte-
rial products to ventilated lungs in a mouse model of
mechanical ventilation. We chose to compare the effect
of LPS to a lipopetide form the outer cell membrane of
bacteria, PAM3.
Methods
Animal preparation
Experiments were carried out in accordance with the
Animal Protection Law of Germany. All experiments
were approved by the local Ethics Committee. 10- to 12-
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week old male C57/Bl6 mice (Charles River Labs, Berlin,
Germany) (25-35 g) were anesthetized by intraperitoneal
injection of ketamine (100 mg/kg) and xylazin (20 mg/
kg). Additional anesthetic was given when animals start
to gain consciousness as assessed by positive testing of
paw reflex. Body temperature was maintained with a
homeothermic blanket system with flexible probe (Har-
vard Apparatus, Holliston, USA). After tracheostomy
with a secured 18-gauge metal cannula mechanical venti-
lation was initiated using a flexivent (Scireq, Montreal,
Canada) computer-controlled small animal ventilator.
Oxygen saturation and pulse rate were monitored using
the MouseOx oximeter (Starr Life Science, Pittburgh,
PA). The sensor was placed on the back leg along the leg
axis. The mice were covered throughout the experiments
to maintain body temperature.
Protocols
After anesthesia mice were randomized to different
groups. All mice were mechanically ventilated with a tidal
volume (Vt) of 10 ml/kg and a positive end-expiratory
pressure (PEEP) of 2 cm H2O. Breath rate was 120/min.
Inspiratory fraction of oxygen was 0.21 (normal air). 9
mice were only ventilated without any challenge (control
group). Intratracheal application was performed 30 min
after start of ventilation with the nebulizer system form
flexivent (Ana-B1/8, Scireq, Montreal, Canada) because
after 30 min a plateau was reached for resistance. The
total volume of solution was 50 μL (in 10 sec) in every
condition. Challenges included sterile saline (sham, N =
5), 1 μg LPS (N = 6), 5 μg LPS (N = 8), 50 nM PAM3 (N =
5), and 200 nM PAM3 (N = 6). After 120 min of ventila-
tion animals were sacrificed. At the end of each experi-
ment the lung of each animal was divided into two parts.
One part was immediately snap frozen in liquid nitrogen
for later RNA extraction. The other part was put into for-
malin for later histological examination.
Lung function measurements
At the beginning, every 15 min and at the end of mechan-
ical ventilation a TLC (total lung capacity) manoeuvre
was performed. With this manoeuvre lungs are inflated
with a pressure of up to 30 cm H2O for a total of six sec-
onds in order to standardize the volume history and to
prevent pre-existing atelectasis. During mechanical ven-
tilation lung function measurements were performed
every 5 min using the flexivent ventilator. Resistance and
compliance were determined with forced manoeuvres
(volume of approximately 200 μl) on the basis of a single
compartment model of the lungs as described previously
[13]. Newtonian resistance, tissue damping and elastance
were obtained using the forced oscillation technique that
fits the constant-phase model to input impedence [13].
Briefly, this perturbation involves an 8-s signal, which uti-
lizes a range of frequencies, including 0.5, 0.75, 1.25, 1.75,
2.75, 3.25, 4.25, 4.75, 5.75, 7.25, 9.25, 10.25, 11.75, 14.75,
16.75, 18.25, and 19.75 Hz.
Histological measurements
Prior to fixation lungs were inflated until total lung
capacity. Formalin fixed tissue specimens were sectioned
and stained with hematoxilin eosin (HE) according to
standard protocols. Numbers of polymorphonuclear leu-
kocytes (PMN) were counted per high powered field
(0.25 mm2) by two independent observers in a blinded
fashion. The within observer coefficient of variation was
less than 5%.
RNA extraction and reverse transcription
RNA from whole lung tissue samples was extracted using
an RNeasy Mini Kit (Qiagen). Reverse transcription was
performed with 0.5-1.0 μg of RNA per reaction using
Superscript II reverse transcriptase (RT, 200 U per reac-
tion) (Invitrogen) and oligo-dT in the presence of an
RNase inhibitor (RNase Out, Invitrogen). The RNA was
reverse transcribed in 30 μl of total volume at 65°C for 10
min, at 42°C for 60 min, and at 100°C for 1 min. The
resultant first-strand complementary DNA (cDNA) was
used as template for PCR.
Quantitative real time PCR (QRTPCR)
QRTPCR was carried out using a LightCycler system
(Roche Diagnostics, Mannheim, Germany). Macrophage
inflammatory protein (MIP)-2 mRNA, tumour necrosis
factor (TNF)α mRNA and hypoxanthine phosphoribosyl-
transferase (HPRT) mRNA expression was quantified
using QRTPCR. MIP-2 and TNFα were selected as pro-
inflammatory cytokines with well known up-regulation
in VILI and after LPS challenge. HPRT was used as house
keeping gene. Primers were based on published mRNA
sequences and were designed to span at least two exons
in order to avoid binding to genomic DNA. Specific
amplification using these primers was confirmed by
ethidium bromide staining of the predicted size of the
PCR products on an agarose gel. PCR was performed
using the QuantiTect SYBR Green PCR Kit (Qiagen) with
the appropriate primers and samples according to the
manufacturer's protocol. In brief, 1 μl of cDNA was
added to 10 μl of 2× QuantiTect SYBR Green PCR master
mix, 8 μl of RNase-free water, and 0.5 μl of each primer
(20 μM) resulting in a total volume of 20 μl. All PCR
experiments were carried out in triplicate.
Statistics
Changes in lung function parameters were assessed by
comparison of the values at the time of challenge (30 min
after the beginning of ventilation) and the values at the
end of the experiment (120 min). For comparison of val-
ues at the beginning and at the end of the experiment inHauber et al. BMC Pulmonary Medicine 2010, 10:20
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one group a paired t test was used. For comparison
between different groups an overall ANOVA on ranks,
followed by multiple testing with the Bonferroni correc-
tion, was performed. Differences between groups were
assessed by means of post hoc pairwise comparison with
the Dunnet test (Systat version 7.0, SPSS Inc, USA). A P
value of less than 0.05 was considered statistically signifi-
cant. All values are given as means ± SD if not otherwise
stated.
Results
Effect of LPS and PAM3 on lung function parameters
Resistance increased during mechanical ventilation in all
groups (Figure 1A). The strongest increase was observed
with PAM3. PAM3 at concentrations of 50 nM and 200
nM significantly increased total resistance (R; 2.1-fold
and 1.9-fold, respectively) and tissue damping (G; 1.7-fold
and 2.3-fold) from the time of challenge to the end of the
experiment (P < 0.05) (Figure 2A). No significant effect
was observed with Newtonian resistance (Rn) (Figure
2A). Sham challenge and LPS challenge had no significant
effects on these parameters (P > 0.05) (Figure 1A and 2A).
Stimulation with PAM3 also significantly increased
elastance (1.9-fold and 2.4-fold, respectively) (P < 0.05).
No significant effect was noted in the other groups (P >
0.05) (Figure 2B). Compliance decreased during mechan-
ical ventilation in all groups (Figure 1B). PAM3 led to a
significant decrease (60% and 40%, respectively) (P <
0.05) whereas no significant reduction was observed in
the other groups (Figure 2C).
Effect of LPS and PAM3 on oxygen saturation and heart rate
There was no statistically significant difference in oxygen
saturation and heart rate between the control group, the
sham group and the challenge groups (data not shown) (P
> 0.05).
Effect of LPS and PAM3 on pro-inflammatory cytokine 
expression
Mechanical ventilation alone significantly increased MIP-
2 and TNFα mRNA expression in the lungs compared to
spontaneously breathing controls (33.3-fold and 5.7-fold,
respectively; P < 0.05). Intratracheal challenge with NaCl
(sham) further increased cytokine expression. This effect
was significant for TNFα (4.4-fold; P < 0.05) but not for
MIP-2 (1.7-fold; P > 0.05) compared to ventilation alone.
LPS significantly increased MIP-2 (5.5-fold and 7.9-fold,
respectively; P < 0.05) and TNFα mRNA expression
(15.1-fold and 36.3-fold, respectively; P < 0.05) in a dose
dependent manner compared to sham challenge. PAM3
also significantly increased MIP-2 (3.3-fold and 3.2-fold,
respectively; P < 0.05) and TNFα mRNA expression (9.4-
fold and 11.8-fold, respectively; P < 0.05) compared to
sham challenge. No dose dependency was observed with
PAM3. LPS had a stronger effect on cytokine expression
compared to PAM3 reaching statistical significance at a
dose of 5 ng/mL (P < 0.05) (Figure 3A and 3B).
Effect of LPS and PAM3 on neutrophil inflammation in 
ventilated lungs
Ventilation alone as well as sham challenge had no signif-
icant effect on the numbers of neutrophils in the lungs
Figure 1 Relative changes in resistance (A) and compliance (B) during mechanical ventilation alone and after challenge with sterile saline 
(sham), LPS (1 μg and 5 μg) and PAM3 (50 nM and 200 nM). Mean values are shown.Hauber et al. BMC Pulmonary Medicine 2010, 10:20
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compared to spontaneously breathing animals (23.0 ±
2.1/field and 18.6 ± 2.2/field vs 20.0 ± 2.5/field) (P > 0.05).
LPS increased neutrophil numbers in a dose dependent
manner. This effect was significant at a dose of 5 μg (35.0
± 4.0/field) compared to sham (P < 0.05). PAM3 also sig-
nificantly increased numbers of neutrophils being signifi-
cant at both tested concentrations (34.0 ± 1.5/field and
38.3 ± 2.6/field) (P < 0.05) (Figure 4 and 5).
Discussion
In the present study we investigated the effects of inhala-
tion of Gram-negative and Gram-positive bacterial prod-
ucts on mechanically ventilated lungs. We found that
both LPS and PAM3 augmented lung inflammation.
Moreover, PAM3 but not LPS led to a significant increase
in pulmonary resistance.
Previous studies have demonstrated inflammation due
to mechanical ventilation [7,14]. In those studies mostly
high tidal volume ventilation was compared to low tidal
ventilation (protective ventilation) [15,16]. Several
reports have demonstrated that LPS can further increase
VILI or can augment inflammation in lungs receiving a
protective ventilation strategy. However, in those studies
LPS was applied before beginning of ventilation or sys-
temically [10-12]. Data on the effect of LPS application on
already ventilated lungs are sparse. Therefore we chal-
lenged ventilated animals with LPS. Agreeing with previ-
ous data we found increased inflammation when LPS was
added to ventilated lungs.
PAM3 is a lipopetide from bacteria that binds to TLR-2
[17]. Although up-regulation of TLR-2 by mechanical
ventilation has been reported previously data on the
effect of PAM3 on ventilated lungs are sparse [18]. In the
present study PAM3 enhanced ventilator-associated
inflammation similar to LPS. However, the effect of LPS
on pro-inflammatory cytokine expression and neutrophil
influx was stronger compared to PAM3. We did not mea-
sure protein levels of cytokines in bronchoalveolar lavage
fluid but previous studies have shown increased cytokine
protein levels after LPS challenge [10]. It is not very likely
that there may be difference between mRNA and protein
expression after PAM3 challenge. However, this has to be
considered as a limitation of our study.
We did not challenge unventilated mice with LPS or
PAM3. Therefore we can only compare the effect of LPS
and PAM3 in ventilated mice. However, both LPS and
PAM3 further enhanced inflammation in ventilated lungs
compared to sham challenge.
In the present study we show for the first time that a
TLR-2 agonist, PAM3, is able to augment ventilator-asso-
Figure 2 Relative changes of lung function parameters from time of stimulation (30 min) to the end of ventilation (120 min). A: Resistance 
(R) and tissue damping (G) significantly increased after PAM3 (P < 0.05) but not in the other groups. No significant change was observed for Newtonian 
resistance (Rn) (P > 0.05). B: Elastance (H) significantly increased with PAM3 (P < 0.05). C: Compliance (C) was significantly decreased after stimulation 
with PAM3 (P < 0.05).Hauber et al. BMC Pulmonary Medicine 2010, 10:20
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ciated inflammation. Recent data from the literature have
questioned the role of TLR-2 in ventilator-induced
inflammation [18]. Our results do not necessarily support
a role for TLR-2 in the pathogenesis of VILI but they
show that TLR-2 activation may be important in enhanc-
ing ventilator-induced inflammation. This finding is sup-
ported by clinical practice since VAP caused by Gram-
positive bacteria can be observed frequently [10]. How-
ever, our study was not designed to investigate suscepti-
bility to infection in ventilated lungs. The role of TLR-2 in
this setting remains to be further evaluated.
Interestingly in our study PAM3 challenge led to a sig-
nificant increase in resistance compared to LPS and sham
challenge. LPS has been shown to induce pulmonary and
vascular hyperreactivity in mice [19]. In that study LPS
had no effect on resistance. LPS has also been demon-
strated to induce bronchial hyperresponsiveness in
humans [20]. We found no increase in pulmonary resis-
tance after LPS. This agrees with data from previous
reports. In contrast the functional effects of TLR-2 ago-
nists have not been characterized very well. To our
knowledge this is the first study to investigate the effect of
Figure 3 MIP-2 (A) and TNFα (B) gene expression in the mouse lung of spontaneously breathing animals (w/o, without mechanical venti-
lation) and mechanical ventilated animals without challenge (control), with intratracheal saline challenge (sham) and with challenge with 
LPS or PAM3 at different doses. Bars indicate mean+SEM. *: P < 0.05 vs spontaneously breathing mice. **: P < 0.05 vs control. +: P < 0.05 vs sham. § 
P < 0.05 vs PAM3 challenge.Hauber et al. BMC Pulmonary Medicine 2010, 10:20
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intratracheal PAM3 application on lung function param-
eters. At present it remains unclear how PAM3 augments
pulmonary resistance. However, using more sophisti-
cated analysis we found that PAM3 increased total resis-
tance and tissue damping which represents tissue
resistance. In contrast, no effect was observed in resis-
tance of the central airways (Newtonian resistance). This
finding suggests that PAM3 has an effect in the lung
parenchyma and in the small airways but not in the cen-
tral airways. In addition, only PAM3 challenge signifi-
cantly decreased compliance and led to a significant
increase in elastance.
Conclusion
In conclusion in our study we found that both LPS and
PAM3 can further increase ventilator-induced inflamma-
tion. In contrast to LPS PAM3 significantly increased
resistance. The underlying mechanisms are under current
investigation. It is tempting to speculate that bacterial
infection of ventilated lungs amplifies VILI and that
increased resistance due to PAM3 in case of Gram-posi-
tive bacterial infection may support bacterial coloniza-
tion and airway obstruction. Future studies will have to
further evaluate the effect of PAM3 on ventilated lungs
and ventilator-associated inflammation.
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Figure 4 Numbers of polymorphonuclear cells (PMN) per high powered field in the mouse lung of spontaneously breathing animals (w/o, 
without mechanical ventilation) and mechanical ventilated animals without challenge (control), with intratracheal saline challenge (sham) 
and with challenge with LPS or PAM3 at different doses. Bars indicate mean+SEM. *: P < 0.05 vs sham.
Figure 5 Histology sections of mouse lungs with ventilation 
alone (A), after sham challenge (B), after LPS challenge (5 μg) (C), 
and after PAM3 challenge (200 nM) (D). HE staining. Original magni-
fication ×100.Hauber et al. BMC Pulmonary Medicine 2010, 10:20
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